Registry of Aortic Valve Bioprostheses Established by Catheter
Registry of Aortic Valve Bioprostheses Established by Catheter
Register multicenter, prospective, open, non-randomized implantation of percutaneous aortic
 bioprostheses through for the treatment of severe degenerative aortic stenosis
 Epidemiological data and the 1-year survival of aortic bioprostheses implanted by
 percutaneous.
Aortic valve stenosis is a serious chronic life-threatening in the short or medium term since
 the onset of functional symptoms. Aortic valve replacement surgery is currently the treatment
 of choice. It is done by surgery with sternotomy and extracorporeal circulation. However,
 despite the considerable improvement of the conditions of care per and post operative, this
 procedure is sometimes burdened with high mortality, especially in the population with severe
 co-morbidities and / or many. For this reason, some patients are considered against the
 indicated surgery or high surgical risk.

 The recent development of aortic valve bioprostheses implanted with new approaches (pressure
 or transapical) can be considered for aortic valve replacement in a population that was
 previously excluded.

 Based on very thorough evaluation of these valves test benches and animal as well as human
 settlements achieved through multiple studies and registries mono or multi patients
 challenged by cardiac surgeons or considered at high surgical risk, it is clear that the
 implementation of these valves could allow, under conditions of optimal implementation and
 monitoring, improve short-and long-term clinical status, quality of life and prognosis of
 patients.

 FRANCE 2 registry, established in 2010, and whose inclusions ended 30 June 2012 has allowed
 an initial assessment of aortic valve bioprostheses implanted catheter The following registry
 France 2 has been requested by the highest authorities of health, FRANCE register TAVI is
 performed in continuity FRANCE 2. It takes account of the first data FRANCE 2. Data Report
 Form has been reduced, no new item has been added, it will be carried out in all centers
 authorized in France to implement this technique. The collection of data will TAVI France
 under the same conditions as those FRANCE 2, the database will be managed by the French
 Society of Cardiology
Inclusion Criteria:

 1. - Existence of senile degenerative aortic stenosis with a transvalvular gradient by>
 40 mmHg and / or maximum velocity> 4 m / sec and / or initial valve area <1 cm ²
 (indexed <0.6 cm ² / m²). The initial measurement of valve area must be obtained
 within 30 days prior to valve implantation

 2. - Presence of symptoms related to aortic stenosis (dyspnea, angina, syncope effort
 ...) demonstrated by Functional Classification for Congestive Heart Failure functional
 class> 2 or Class I, but with left ventricular dysfunction (ejection fraction <40% )

 3. - A Score to "EuroSCORE" (Logistic European system for cardiac operative risk
 evaluation) > 20% and / or Society of Thoracic Surgeons' risk Calculator> 10. In case
 the "EuroSCORE" <20% or STS <10, confirmed that some comorbidities were not captured
 by these indices will be produced by the surgeon and cardiologist

 Some patients are in a situation against medical-cardiac surgery indicates heavy
 although this does not appear in the predictive risk assessment through the scores. In
 this regard, patients may be included in the following conditions:

 3-1 - ascending aorta very calcified ("porcelain") 3-2 - Any other condition
 preventing cannulation for cardiopulmonary bypass, aortic clamping, or access
 mediastinal surgery: History of 3-2-1 against mediastinal irradiation indicating
 open-chest 3-2-2 thoracic deformity or history of mediastinitis-cons indicating the
 opening of the thorax 3-2-3 Other (eg, history of coronary bypass surgery may indicate
 against the opening of the thorax)

 4. - The patient accepts the scheduled evaluations at follow-up clinic

 5. - The patient or his legal representatives were informed of the nature of valve
 implantation and associated register and accept the conditions.

 Exclusion Criteria:

 -  none